CRIPTO3, a presumed pseudogene, is expressed in cancer

Biochemical and Biophysical Research Communications

Volumn 377, Issue 1, 2008, Pages 215-220

  Sun, Chao ^a   Orozco, Olivia ^a   Olson, Dian L ^a   Choi, Eugene ^a   Garber, Ellen ^a   Tizard, Rich ^a   Szak, Suzanne ^a   Sanicola, Michele ^a   Carulli, John P ^a  

^a BIOGEN   (United States)

Author keywords

Cancer; CRIPTO; Gene expression; Retrogene; RT PCR; TDGF

Indexed keywords

AMINO ACID; CELL SURFACE PROTEIN; MESSENGER RNA; PROTEIN CRIPTO 1; PROTEIN CRIPTO 3; PROTEIN NODAL; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; CRIPTO1 GENE; CRIPTO3 GENE; GENE; GENE ACTIVATION; GENE EXPRESSION; GENE STRUCTURE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; NEOPLASM; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERIAL ANALYSIS OF GENE EXPRESSION; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HUMANS; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; NEOPLASMS; PSEUDOGENES; TRANSCRIPTION, GENETIC;

EID: 54449091351     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.09.113     Document Type: Article

References (28)

1. Gritsman K., Zhang J., Cheng S., Heckscher E., Talbot W.S., and Schier A.F. The EGF-CFC protein one-eyed pinhead is essential for nodal signaling. Cell 97 (1999) 121-132
2. Minchiotti G., Manco G., Parisi S., Lago C.T., Rosa F., and Persico M.G. Structure-function analysis of the EGF-CFC family member Cripto identifies residues essential for nodal signalling. Development 128 (2001) 4501-4510
3. Saloman D.S., Bianco C., Ebert A.D., Khan N.I., De Santis M., Normanno N., Wechselberger C., Seno M., Williams K., Sanicola M., Foley S., Gullick W.J., and Persico G. The EGF-CFC family: novel epidermal growth factor-related proteins in development and cancer. Endocr. Relat. Cancer 7 (2000) 199-226
4. Strizzi L., Bianco C., Normanno N., and Salomon D. Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis. Oncogene 24 (2005) 5731-5741
5. de la Cruz J.M., Bamford R.N., Burdine R.D., Roessler E., Barkovich A.J., Donnai D., Schier A.F., and Muenke M. A loss-of-function mutation in the CFC domain of TDGF1 is associated with human forebrain defects. Hum. Genet. 110 (2002) 422-428
6. Ding J., Yang L., Yan Y.T., Chen A., Desai N., Wynshaw-Boris A., and Shen M.M. Cripto is required for correct orientation of the anterior-posterior axis in the mouse embryo. Nature 395 (1998) 702-707
7. Li S.S., Liu Y.H., Tseng C.N., Chung T.L., Lee T.Y., and Singh S. Characterization and gene expression profiling of five new human embryonic stem cell lines derived in Taiwan. Stem Cells Dev. 15 (2006) 532-555
8. Adkins H.B., Bianco C., Schiffer S.G., Rayhorn P., Zafari M., Cheung A.E., Orozco O., Olson D., De Luca A., Chen L.L., Miatkowski K., Benjamin C., Normanno N., Williams K.P., Jarpe M., LePage D., Salomon D., and Sanicola M. Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo. J. Clin. Invest. 112 (2003) 575-587
9. Ciardiello F., Kim N., Saeki T., Dono R., Persico M.G., Plowman G.D., Garrigues J., Radke S., Todaro G.J., and Salomon D.S. Differential expression of epidermal growth factor-related proteins in human colorectal tumors. Proc. Natl. Acad. Sci. USA 88 (1991) 7792-7796
10. Shen M.M. Decrypting the role of Cripto in tumorigenesis. J. Clin. Invest. 112 (2003) 500-502
11. Zhong X.Y., Zhang L.H., Jia S.Q., Shi T., Niu Z.J., Du H., Zhang G.G., Hu Y., Lu A.P., Li J.Y., and Ji J.F. Positive association of up-regulated Cripto-1 and down-regulated E-cadherin with tumour progression and poor prognosis in gastric cancer. Histopathology 52 (2008) 560-568
12. Gong Y.P., Yarrow P.M., Carmalt H.L., Kwun S.Y., Kennedy C.W., Lin B.P., Xing P.X., and Gillett D.J. Overexpression of Cripto and its prognostic significance in breast cancer: a study with long-term survival. Eur. J. Surg. Oncol. 33 (2007) 438-443
13. Shukla A., Ho Y., Liu X., Ryscavage A., and Glick A.B. Cripto-1 alters keratinocyte differentiation via blockade of transforming growth factor-{beta}1 signaling: role in skin carcinogenesis. Mol. Cancer Res. 6 (2008) 509-516
14. Sun Y., Strizzi L., Raafat A., Hirota M., Bianco C., Feigenbaum L., Kenney N., Wechselberger C., Callahan R., and Salomon D.S. Overexpression of human Cripto-1 in transgenic mice delays mammary gland development and differentiation and induces mammary tumorigenesis. Am. J. Pathol. 167 (2005) 585-597
15. Wechselberger C., Strizzi L., Kenney N., Hirota M., Sun Y., Ebert A., Orozco O., Bianco C., Khan N.I., Wallace-Jones B., Normanno N., Adkins H., Sanicola M., and Salomon D.S. Human Cripto-1 overexpression in the mouse mammary gland results in the development of hyperplasia and adenocarcinoma. Oncogene 24 (2005) 4094-4105
16. Hu X.F., Li J., Yang E., Vandervalk S., and Xing P.X. Anti-Cripto Mab inhibit tumour growth and overcome MDR in a human leukaemia MDR cell line by inhibition of Akt and activation of JNK/SAPK and bad death pathways. Br. J. Cancer 96 (2007) 918-927
17. Normanno N., De Luca A., Maiello M.R., Bianco C., Mancino M., Strizzi L., Arra C., Ciardiello F., Agrawal S., and Salomon D.S. CRIPTO-1: a novel target for therapeutic intervention in human carcinoma. Int. J. Oncol. 25 (2004) 1013-1020
18. Xing P.X., Hu X.F., Pietersz G.A., Hosick H.L., and McKenzie I.F. Cripto: a novel target for antibody-based cancer immunotherapy. Cancer Res. 64 (2004) 4018-4023
19. Bianco C., Adkins H.B., Wechselberger C., Seno M., Normanno N., De Luca A., Sun Y., Khan N., Kenney N., Ebert A., Williams K.P., Sanicola M., and Salomon D.S. Cripto-1 activates nodal- and ALK4-dependent and -independent signaling pathways in mammary epithelial cells. Mol. Cell. Biol. 22 (2002) 2586-2597
20. Yeo C., and Whitman M. Nodal signals to Smads through Cripto-dependent and Cripto-independent mechanisms. Mol. Cell 7 (2001) 949-957
21. Bianco C., Strizzi L., Rehman A., Normanno N., Wechselberger C., Sun Y., Khan N., Hirota M., Adkins H., Williams K., Margolis R.U., Sanicola M., and Salomon D.S. A Nodal- and ALK4-independent signaling pathway activated by Cripto-1 through Glypican-1 and c-Src. Cancer Res. 63 (2003) 1192-1197
22. Gray P.C., Shani G., Aung K., Kelber J., and Vale W. Cripto binds transforming growth factor beta (TGF-beta) and inhibits TGF-beta signaling. Mol. Cell. Biol. 26 (2006) 9268-9278
23. Dono R., Montuori N., Rocchi M., De Ponti-Zilli L., Ciccodicola A., and Persico M.G. Isolation and characterization of the CRIPTO autosomal gene and its X-linked related sequence. Am. J. Hum. Genet. 49 (1991) 555-565
24. Scognamiglio B., Baldassarre G., Cassano C., Tucci M., Montuori N., Dono R., Lembo G., Barra A., Lago C.T., Viglietto G., Rocchi M., and Persico M.G. Assignment of human teratocarcinoma derived growth factor (TDGF) sequences to chromosomes 2q37, 3q22, 6p25 and 19q13.1. Cytogenet. Cell Genet. 84 (1999) 220-224
25. Hentschke M., Kurth I., Borgmeyer U., and Hubner C.A. Germ cell nuclear factor is a repressor of CRIPTO-1 and CRIPTO-3. J. Biol. Chem. 281 (2006) 33497-33504
26. Bhattacharya B., Miura T., Brandenberger R., Mejido J., Luo Y., Yang A.X., Joshi B.H., Ginis I., Thies R.S., Amit M., Lyons I., Condie B.G., Itskovitz-Eldor J., Rao M.S., and Puri R.K. Gene expression in human embryonic stem cell lines: unique molecular signature. Blood 103 (2004) 2956-2964
27. Ciardiello F., Dono R., Kim N., Persico M.G., and Salomon D.S. Expression of cripto, a novel gene of the epidermal growth factor gene family, leads to in vitro transformation of a normal mouse mammary epithelial cell line. Cancer Res. 51 (1991) 1051-1054
28. Normanno N., De Luca A., Bianco C., Maiello M.R., Carriero M.V., Rehman A., Wechselberger C., Arra C., Strizzi L., Sanicola M., and Salomon D.S. Cripto-1 overexpression leads to enhanced invasiveness and resistance to anoikis in human MCF-7 breast cancer cells. J. Cell. Physiol. 198 (2004) 31-39